A combination of the herbal extracts curcumin and Qing Dai can induce remission in a significant proportion of patients with active ulcerative colitis (UC), according to the results of a phase 2 placebo-controlled trial.
The study included 42 adults with active UC who were randomly assigned (2:1) to an enteric-coated pill containing 3 g of curcumin and Qing Dai (CurQD) or placebo for 8 weeks. Phytomedicine Research And Development
The coprimary outcome was a clinical response (reduction in Simple Clinical Colitis Activity Index ≥ 3 points) and an objective response (Mayo endoscopic sub-score improvement ≥ 1 or 50% fecal calprotectin reduction).
Responding patients continued either maintenance curcumin alone or placebo for an additional 8 weeks.
Aryl-hydrocarbon receptor (AhR) activation was assessed by Cyp1A1 mucosal expression.
Of the CurQD patients, 43% met the coprimary endpoint of a significant reduction in disease activity and objective evidence of response, vs 8% of the placebo patients (P = .033).
A clinical response was observed in 86% of the CurQD patients vs 31% of the placebo patients (P < .001) and clinical remission in 50% and 8%, respectively (P = .01).
Endoscopic improvement was observed in 75% of the CurQD patients vs 20% of the placebo patients (P = .036). The responses were maintained at 16 weeks with maintenance curcumin alone.
CurQD uniquely activated the AhR-pathway implicated as a mediator of inflammatory bowel disease (IBD).
"More studies are warranted to investigate this nutraceutical treatment strategy in UC and to interrogate AhR pathway as a possible novel therapeutic target in IBD," the authors write.
The study was led by Shomron Ben-Horin, MD, of Sheba Medical Center in Tel Aviv, Israel. It was published online June 9 in Clinical Gastroenterology & Hepatology. The study had no commercial funding.
Limitations include a modest cohort size and the absence of histologic outcomes.
Several of the authors received consultant and/or speaker fees from various pharmaceutical companies.
For more news, follow Medscape on Facebook , Twitter , Instagram , and YouTube
Credits: Lead image: Medscape Illustration: Kjetil Kolbjornsrud/Dreamstime
Medscape Medical News © 2023 WebMD, LLC
Send news tips to news@medscape.net.
Cite this: Herbal Combination Shows Promise in Active Ulcerative Colitis - Medscape - Jun 15, 2023.
You have already selected for My Alerts
Click the topic below to receive emails when new articles are available.
Botanical Drug Development You've successfully added to your alerts. You will receive email when new content is published.